AACR: Triple-Negative Breast Cancer—Utilizing Biomarkers for Better Therapeutic Strategies

The breast cancer field now understands that triple-negative breast cancer (TNBC) comprises a heterogeneous set of tumor types. How to parse TNBC into distinct subtypes? One current approach is to study subtypes of TNBC and target their specific features. Another way is to specifically target the genetics of these cancers.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news